CIK 0001710072 · Large accelerated filer
Edgewise Therapeutics, Inc.
Sign in to watch- Ticker
- EWTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 821725586
- Phone
- 720-262-7002
- Business address
- 1715 38TH ST, BOULDER, CO, 80301
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $201,787
- in 1 filing
Net −$201,787. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-08-12 | Derakhshan Behrad Chief Business Officer | Option exercise | +7,500 | 36,926 | ||
| 2026-08-12 | Derakhshan Behrad Chief Business Officer | Sale | −2,171 | $43.79 | $95K | 34,755 |
| 2026-08-12 | Derakhshan Behrad Chief Business Officer | Sale | −304 | $44.50 | $14K | 34,451 |
| 2026-08-12 | Derakhshan Behrad Chief Business Officer | Sale | −150 | $44.44 | $7K | 34,301 |
| 2026-08-12 | Derakhshan Behrad Chief Business Officer | Sale | −2,475 | $43.70 | $108K | 31,826 |
| 2026-08-12 | Derakhshan Behrad Chief Business Officer | Option exercise · Restricted Stock Units | −5,781 | 11,563 | ||
| 2026-08-12 | Derakhshan Behrad Chief Business Officer | Option exercise · Restricted Stock Units | −7,500 | 22,500 | ||
| 2026-08-12 | Derakhshan Behrad Chief Business Officer | Grant or award · Restricted Stock Units | +50,000 | 50,000 | ||
| 2026-08-12 | Derakhshan Behrad Chief Business Officer | Grant or award · Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2026-08-12 | Nofi Michael Chief Financial Officer | Grant or award · Restricted Stock Units | +24,375 | 24,375 | ||
| 2026-08-12 | Nofi Michael Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +48,750 | 48,750 | ||
| 2026-08-12 | Donovan Joanne M. CMO | Option exercise | +5,781 | 11,035 | ||
| 2026-08-12 | Donovan Joanne M. CMO | Option exercise | +7,031 | 18,066 | ||
| 2026-08-12 | Donovan Joanne M. CMO | Sale | −2,839 | $43.78 | $124K | 15,227 |
| 2026-08-12 | Donovan Joanne M. CMO | Sale | −2,779 | $43.71 | $121K | 12,448 |
| 2026-08-12 | Donovan Joanne M. CMO | Sale | −104 | $44.43 | $5K | 12,344 |
| 2026-08-12 | Donovan Joanne M. CMO | Sale | −800 | $44.52 | $36K | 11,544 |
| 2026-08-12 | Donovan Joanne M. CMO | Option exercise · Restricted Stock Units | −5,781 | 11,563 | ||
| 2026-08-12 | Donovan Joanne M. CMO | Option exercise · Restricted Stock Units | −7,031 | 21,094 | ||
| 2026-08-12 | Donovan Joanne M. CMO | Grant or award · Restricted Stock Units | +32,500 | 32,500 |
Page 2 of 26 · 509 trades